tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV

KalVista Pharmaceuticals (KALV) Similar Stocks

Compare
413 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
KalVista Pharmaceuticals
$12.99
$645.81M
20.50%
10 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$7.23
$770.93M
-67.11%
14 Buy
1 Hold
0 Sell
Strong Buy
Dianthus Therapeutics
$21.67
$696.17M
0.79%
6 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$9.05
$696.98M
40.97%
7 Buy
0 Hold
0 Sell
Strong Buy
LENZ Therapeutics
$26.87
$740.08M
70.93%
8 Buy
0 Hold
0 Sell
Strong Buy
GH Research
$9.53
$591.13M
-9.32%
9 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KALV
KalVista Pharmaceuticals
12.99
1.98
17.98%
RCKT
Rocket Pharmaceuticals
7.23
-14.62
-66.91%
DNTH
Dianthus Therapeutics
21.67
-0.23
-1.05%
REPL
Replimune Group
9.05
2.47
37.54%
LENZ
LENZ Therapeutics
26.87
10.37
62.85%
GHRS
GH Research
9.53
-1.22
-11.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis